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Background
The association between prior seropositivity to human
adenovirus (HAd) type 5 and increased HIV acquisition in
the Step Vaccine Study has raised questions concerning
the frequency of endemic HAd infection in adults. Few
studies have documented the frequency and types of HAd
infections in HIV-infected populations using sensitive
molecular methods. In this study we retrospectively tested
rectal swabs collected from a prospective cohort of Peru-
vian HIV-positive MSM for the presence of HAds.
Methods
Swabs were collected from 20 individuals (median CD4+
T cells 406/μl, median plasma HIV viral load 4.3 log10
cop/ml) three times/week for 18 weeks. Viral DNA was
eluted from the swabs in 1 ml proteinase K, and amplified
using a sensitive multiplex PCR assay that detects all cur-
rently recognized HAd serotypes. Molecular typing of
identified viruses was performed on a subset of samples
by partial-length hexon gene sequencing.
Results
Fifteen of the twenty individuals (75%) shed HAd inter-
mittently. CD4 count and plasma HIV-1 viral load did not
differ between participants with and without HAd shed-
ding (Mann-Whitney, p = 0.349 and p = 0.497, resp.).
Among shedders, HAd was detected in 30% of samples
(range 2.0% to 64.7%) with a mean of 6.1 × 103 adenovi-
rus copies/ml of eluate (range 1.51 × 102 – 2.2 × 108 cop-
ies/ml). HAd shedding typically occurred on consecutive
days in distinctly clustered episodes lasting a median of 4
days (range 1 to 9 days) separated by periods without
shedding. At least 21 HAd types from species B, C, and D
were identified, including Ad5, Ad26 and Ad48. Eight of
fifteen shedders (53%) had more than one serotype
present.
Conclusion
In conclusion, we found a high prevalence of rectal shed-
ding of diverse human adenoviruses among HIV-positive
MSM, including serotypes presently under consideration
as vaccine vectors.
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